Collaborative research partnerships using physiologically relevant 3D tissue models and AI-driven architectural analysis
Purely Grow partners with academic investigators to accelerate research in cancer biology, tissue engineering, fibrosis, microenvironment-driven disease, and drug response modeling.
By integrating ColFi3D™ native collagen tissue reconstruction with FibroAI™ architectural analysis, we provide tools to study human tissue behavior in a physiologically meaningful 3D context.
Our goal is to strengthen the translational bridge between bench research and clinical relevance.
Why Collaborate With Purely Grow?
Many in vitro systems lack:
- Native extracellular matrix architecture
- Physiological mechanical stiffness
- Vascular-like organization
- Tissue-level analytical metrics
ColFi3D™ recreates matrix-rich 3D tissue environments, while FibroAI™ quantifies structural organization at the architectural level.
Together, these platforms enable deeper investigation of how cells interact with their microenvironment.
Collaboration Areas
Cancer Biology
- Tumor microenvironment modeling
- Matrix-driven invasion and metastasis
- Drug response heterogeneity
- Tumor normalization studies
Fibrosis & Matrix Remodeling
- Collagen reorganization dynamics
- Stiffness-dependent signaling
- Microenvironment-driven phenotypes
Tissue Engineering & Regenerative Medicine
- 3D tissue reconstruction
- Vascular network formation
- Long-term viability studies
- Biomaterial–cell interaction analysis
Drug Response & Mechanism Studies
- Phenotypic screening in 3D
- Architectural response metrics
- Structural normalization analysis
- Early efficacy signal detection
What We Provide
ColFi3D™ Platform Access
- Native insoluble collagen fiber scaffolds
- 3D tissue fabrication workflows
- Customized matrix configurations
FibroAI™ Analytical Support
- Structural pattern recognition
- Vascular network quantification
- Tissue normalization scoring
- Multi-parameter phenotypic analysis
Experimental Design Collaboration
- Study planning support
- Imaging protocol optimization
- Data interpretation assistance
Collaboration Models
We offer flexible engagement structures:
- Joint grant submissions (NIH, NSF, DoD, etc.)
- Sponsored research agreements
- Co-development partnerships
- Material transfer agreements (MTAs)
- Co-authored publications
Publication & Intellectual Property
We support:
- Peer-reviewed co-publications
- Data-sharing for grant applications
- Clear IP frameworks for joint discoveries
Patent-protected core technologies remain owned by Purely Grow, while new discoveries arising from collaboration can be structured according to mutually agreed terms.
Translational Impact
By integrating matrix architecture and AI-driven analysis, collaborative studies can:
- Improve physiological relevance of in vitro findings
- Strengthen grant proposals with innovative modeling systems
- Enhance translational credibility
- Generate higher-impact publications
Our Vision for Academic Partnerships
We believe the next generation of biomedical discovery requires:
- Human-relevant 3D systems
- Matrix-aware experimental design
- Quantitative architectural analytics
- Cross-disciplinary collaboration
Purely Grow seeks to work alongside academic leaders to redefine how human tissue is studied in the laboratory.
For collaboration inquiries, grant discussions, or platform access requests, please contact Purely Grow.
